Global Neurological Biomarkers Market Research Report 2024(Status and Outlook)
Report Overview
A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
This report provides a deep insight into the global Neurological Biomarkers market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neurological Biomarkers Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neurological Biomarkers market in any manner.
Global Neurological Biomarkers Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
Market Segmentation (by Type)
Proteomics
Genomics
Imaging
Bioinformatics
Others
Market Segmentation (by Application)
Diagnostics
Drug Discovery
Personalized Medicine
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurological Biomarkers Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
This report provides a deep insight into the global Neurological Biomarkers market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neurological Biomarkers Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neurological Biomarkers market in any manner.
Global Neurological Biomarkers Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
Market Segmentation (by Type)
Proteomics
Genomics
Imaging
Bioinformatics
Others
Market Segmentation (by Application)
Diagnostics
Drug Discovery
Personalized Medicine
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Neurological Biomarkers Market
- Overview of the regional outlook of the Neurological Biomarkers Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurological Biomarkers Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Neurological Biomarkers
1.2 Key Market Segments
1.2.1 Neurological Biomarkers Segment by Type
1.2.2 Neurological Biomarkers Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROLOGICAL BIOMARKERS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neurological Biomarkers Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neurological Biomarkers Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROLOGICAL BIOMARKERS MARKET COMPETITIVE LANDSCAPE
3.1 Global Neurological Biomarkers Sales by Manufacturers (2019-2024)
3.2 Global Neurological Biomarkers Revenue Market Share by Manufacturers (2019-2024)
3.3 Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neurological Biomarkers Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neurological Biomarkers Sales Sites, Area Served, Product Type
3.6 Neurological Biomarkers Market Competitive Situation and Trends
3.6.1 Neurological Biomarkers Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neurological Biomarkers Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEUROLOGICAL BIOMARKERS INDUSTRY CHAIN ANALYSIS
4.1 Neurological Biomarkers Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROLOGICAL BIOMARKERS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEUROLOGICAL BIOMARKERS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurological Biomarkers Sales Market Share by Type (2019-2024)
6.3 Global Neurological Biomarkers Market Size Market Share by Type (2019-2024)
6.4 Global Neurological Biomarkers Price by Type (2019-2024)
7 NEUROLOGICAL BIOMARKERS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurological Biomarkers Market Sales by Application (2019-2024)
7.3 Global Neurological Biomarkers Market Size (M USD) by Application (2019-2024)
7.4 Global Neurological Biomarkers Sales Growth Rate by Application (2019-2024)
8 NEUROLOGICAL BIOMARKERS MARKET SEGMENTATION BY REGION
8.1 Global Neurological Biomarkers Sales by Region
8.1.1 Global Neurological Biomarkers Sales by Region
8.1.2 Global Neurological Biomarkers Sales Market Share by Region
8.2 North America
8.2.1 North America Neurological Biomarkers Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurological Biomarkers Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neurological Biomarkers Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurological Biomarkers Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurological Biomarkers Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Neurological Biomarkers Basic Information
9.1.2 Thermo Fisher Scientific Neurological Biomarkers Product Overview
9.1.3 Thermo Fisher Scientific Neurological Biomarkers Product Market Performance
9.1.4 Thermo Fisher Scientific Business Overview
9.1.5 Thermo Fisher Scientific Neurological Biomarkers SWOT Analysis
9.1.6 Thermo Fisher Scientific Recent Developments
9.2 Merck
9.2.1 Merck Neurological Biomarkers Basic Information
9.2.2 Merck Neurological Biomarkers Product Overview
9.2.3 Merck Neurological Biomarkers Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Neurological Biomarkers SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Quest Diagnostics
9.3.1 Quest Diagnostics Neurological Biomarkers Basic Information
9.3.2 Quest Diagnostics Neurological Biomarkers Product Overview
9.3.3 Quest Diagnostics Neurological Biomarkers Product Market Performance
9.3.4 Quest Diagnostics Neurological Biomarkers SWOT Analysis
9.3.5 Quest Diagnostics Business Overview
9.3.6 Quest Diagnostics Recent Developments
9.4 Abbott
9.4.1 Abbott Neurological Biomarkers Basic Information
9.4.2 Abbott Neurological Biomarkers Product Overview
9.4.3 Abbott Neurological Biomarkers Product Market Performance
9.4.4 Abbott Business Overview
9.4.5 Abbott Recent Developments
9.5 Roche
9.5.1 Roche Neurological Biomarkers Basic Information
9.5.2 Roche Neurological Biomarkers Product Overview
9.5.3 Roche Neurological Biomarkers Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 Illumina
9.6.1 Illumina Neurological Biomarkers Basic Information
9.6.2 Illumina Neurological Biomarkers Product Overview
9.6.3 Illumina Neurological Biomarkers Product Market Performance
9.6.4 Illumina Business Overview
9.6.5 Illumina Recent Developments
9.7 Bio-Rad Laboratories
9.7.1 Bio-Rad Laboratories Neurological Biomarkers Basic Information
9.7.2 Bio-Rad Laboratories Neurological Biomarkers Product Overview
9.7.3 Bio-Rad Laboratories Neurological Biomarkers Product Market Performance
9.7.4 Bio-Rad Laboratories Business Overview
9.7.5 Bio-Rad Laboratories Recent Developments
9.8 QIAGEN
9.8.1 QIAGEN Neurological Biomarkers Basic Information
9.8.2 QIAGEN Neurological Biomarkers Product Overview
9.8.3 QIAGEN Neurological Biomarkers Product Market Performance
9.8.4 QIAGEN Business Overview
9.8.5 QIAGEN Recent Developments
9.9 Myriad RBM
9.9.1 Myriad RBM Neurological Biomarkers Basic Information
9.9.2 Myriad RBM Neurological Biomarkers Product Overview
9.9.3 Myriad RBM Neurological Biomarkers Product Market Performance
9.9.4 Myriad RBM Business Overview
9.9.5 Myriad RBM Recent Developments
9.10 Cisbio Bioassays
9.10.1 Cisbio Bioassays Neurological Biomarkers Basic Information
9.10.2 Cisbio Bioassays Neurological Biomarkers Product Overview
9.10.3 Cisbio Bioassays Neurological Biomarkers Product Market Performance
9.10.4 Cisbio Bioassays Business Overview
9.10.5 Cisbio Bioassays Recent Developments
9.11 Athena Diagnostics
9.11.1 Athena Diagnostics Neurological Biomarkers Basic Information
9.11.2 Athena Diagnostics Neurological Biomarkers Product Overview
9.11.3 Athena Diagnostics Neurological Biomarkers Product Market Performance
9.11.4 Athena Diagnostics Business Overview
9.11.5 Athena Diagnostics Recent Developments
9.12 BGI
9.12.1 BGI Neurological Biomarkers Basic Information
9.12.2 BGI Neurological Biomarkers Product Overview
9.12.3 BGI Neurological Biomarkers Product Market Performance
9.12.4 BGI Business Overview
9.12.5 BGI Recent Developments
9.13 Wuxi APP
9.13.1 Wuxi APP Neurological Biomarkers Basic Information
9.13.2 Wuxi APP Neurological Biomarkers Product Overview
9.13.3 Wuxi APP Neurological Biomarkers Product Market Performance
9.13.4 Wuxi APP Business Overview
9.13.5 Wuxi APP Recent Developments
9.14 Aepodia
9.14.1 Aepodia Neurological Biomarkers Basic Information
9.14.2 Aepodia Neurological Biomarkers Product Overview
9.14.3 Aepodia Neurological Biomarkers Product Market Performance
9.14.4 Aepodia Business Overview
9.14.5 Aepodia Recent Developments
9.15 Proteome Sciences
9.15.1 Proteome Sciences Neurological Biomarkers Basic Information
9.15.2 Proteome Sciences Neurological Biomarkers Product Overview
9.15.3 Proteome Sciences Neurological Biomarkers Product Market Performance
9.15.4 Proteome Sciences Business Overview
9.15.5 Proteome Sciences Recent Developments
9.16 Genewiz
9.16.1 Genewiz Neurological Biomarkers Basic Information
9.16.2 Genewiz Neurological Biomarkers Product Overview
9.16.3 Genewiz Neurological Biomarkers Product Market Performance
9.16.4 Genewiz Business Overview
9.16.5 Genewiz Recent Developments
10 NEUROLOGICAL BIOMARKERS MARKET FORECAST BY REGION
10.1 Global Neurological Biomarkers Market Size Forecast
10.2 Global Neurological Biomarkers Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neurological Biomarkers Market Size Forecast by Country
10.2.3 Asia Pacific Neurological Biomarkers Market Size Forecast by Region
10.2.4 South America Neurological Biomarkers Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neurological Biomarkers by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Neurological Biomarkers Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neurological Biomarkers by Type (2025-2030)
11.1.2 Global Neurological Biomarkers Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neurological Biomarkers by Type (2025-2030)
11.2 Global Neurological Biomarkers Market Forecast by Application (2025-2030)
11.2.1 Global Neurological Biomarkers Sales (Kilotons) Forecast by Application
11.2.2 Global Neurological Biomarkers Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Neurological Biomarkers
1.2 Key Market Segments
1.2.1 Neurological Biomarkers Segment by Type
1.2.2 Neurological Biomarkers Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEUROLOGICAL BIOMARKERS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neurological Biomarkers Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neurological Biomarkers Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEUROLOGICAL BIOMARKERS MARKET COMPETITIVE LANDSCAPE
3.1 Global Neurological Biomarkers Sales by Manufacturers (2019-2024)
3.2 Global Neurological Biomarkers Revenue Market Share by Manufacturers (2019-2024)
3.3 Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neurological Biomarkers Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neurological Biomarkers Sales Sites, Area Served, Product Type
3.6 Neurological Biomarkers Market Competitive Situation and Trends
3.6.1 Neurological Biomarkers Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neurological Biomarkers Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NEUROLOGICAL BIOMARKERS INDUSTRY CHAIN ANALYSIS
4.1 Neurological Biomarkers Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEUROLOGICAL BIOMARKERS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NEUROLOGICAL BIOMARKERS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurological Biomarkers Sales Market Share by Type (2019-2024)
6.3 Global Neurological Biomarkers Market Size Market Share by Type (2019-2024)
6.4 Global Neurological Biomarkers Price by Type (2019-2024)
7 NEUROLOGICAL BIOMARKERS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurological Biomarkers Market Sales by Application (2019-2024)
7.3 Global Neurological Biomarkers Market Size (M USD) by Application (2019-2024)
7.4 Global Neurological Biomarkers Sales Growth Rate by Application (2019-2024)
8 NEUROLOGICAL BIOMARKERS MARKET SEGMENTATION BY REGION
8.1 Global Neurological Biomarkers Sales by Region
8.1.1 Global Neurological Biomarkers Sales by Region
8.1.2 Global Neurological Biomarkers Sales Market Share by Region
8.2 North America
8.2.1 North America Neurological Biomarkers Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurological Biomarkers Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neurological Biomarkers Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurological Biomarkers Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurological Biomarkers Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Neurological Biomarkers Basic Information
9.1.2 Thermo Fisher Scientific Neurological Biomarkers Product Overview
9.1.3 Thermo Fisher Scientific Neurological Biomarkers Product Market Performance
9.1.4 Thermo Fisher Scientific Business Overview
9.1.5 Thermo Fisher Scientific Neurological Biomarkers SWOT Analysis
9.1.6 Thermo Fisher Scientific Recent Developments
9.2 Merck
9.2.1 Merck Neurological Biomarkers Basic Information
9.2.2 Merck Neurological Biomarkers Product Overview
9.2.3 Merck Neurological Biomarkers Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Neurological Biomarkers SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Quest Diagnostics
9.3.1 Quest Diagnostics Neurological Biomarkers Basic Information
9.3.2 Quest Diagnostics Neurological Biomarkers Product Overview
9.3.3 Quest Diagnostics Neurological Biomarkers Product Market Performance
9.3.4 Quest Diagnostics Neurological Biomarkers SWOT Analysis
9.3.5 Quest Diagnostics Business Overview
9.3.6 Quest Diagnostics Recent Developments
9.4 Abbott
9.4.1 Abbott Neurological Biomarkers Basic Information
9.4.2 Abbott Neurological Biomarkers Product Overview
9.4.3 Abbott Neurological Biomarkers Product Market Performance
9.4.4 Abbott Business Overview
9.4.5 Abbott Recent Developments
9.5 Roche
9.5.1 Roche Neurological Biomarkers Basic Information
9.5.2 Roche Neurological Biomarkers Product Overview
9.5.3 Roche Neurological Biomarkers Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 Illumina
9.6.1 Illumina Neurological Biomarkers Basic Information
9.6.2 Illumina Neurological Biomarkers Product Overview
9.6.3 Illumina Neurological Biomarkers Product Market Performance
9.6.4 Illumina Business Overview
9.6.5 Illumina Recent Developments
9.7 Bio-Rad Laboratories
9.7.1 Bio-Rad Laboratories Neurological Biomarkers Basic Information
9.7.2 Bio-Rad Laboratories Neurological Biomarkers Product Overview
9.7.3 Bio-Rad Laboratories Neurological Biomarkers Product Market Performance
9.7.4 Bio-Rad Laboratories Business Overview
9.7.5 Bio-Rad Laboratories Recent Developments
9.8 QIAGEN
9.8.1 QIAGEN Neurological Biomarkers Basic Information
9.8.2 QIAGEN Neurological Biomarkers Product Overview
9.8.3 QIAGEN Neurological Biomarkers Product Market Performance
9.8.4 QIAGEN Business Overview
9.8.5 QIAGEN Recent Developments
9.9 Myriad RBM
9.9.1 Myriad RBM Neurological Biomarkers Basic Information
9.9.2 Myriad RBM Neurological Biomarkers Product Overview
9.9.3 Myriad RBM Neurological Biomarkers Product Market Performance
9.9.4 Myriad RBM Business Overview
9.9.5 Myriad RBM Recent Developments
9.10 Cisbio Bioassays
9.10.1 Cisbio Bioassays Neurological Biomarkers Basic Information
9.10.2 Cisbio Bioassays Neurological Biomarkers Product Overview
9.10.3 Cisbio Bioassays Neurological Biomarkers Product Market Performance
9.10.4 Cisbio Bioassays Business Overview
9.10.5 Cisbio Bioassays Recent Developments
9.11 Athena Diagnostics
9.11.1 Athena Diagnostics Neurological Biomarkers Basic Information
9.11.2 Athena Diagnostics Neurological Biomarkers Product Overview
9.11.3 Athena Diagnostics Neurological Biomarkers Product Market Performance
9.11.4 Athena Diagnostics Business Overview
9.11.5 Athena Diagnostics Recent Developments
9.12 BGI
9.12.1 BGI Neurological Biomarkers Basic Information
9.12.2 BGI Neurological Biomarkers Product Overview
9.12.3 BGI Neurological Biomarkers Product Market Performance
9.12.4 BGI Business Overview
9.12.5 BGI Recent Developments
9.13 Wuxi APP
9.13.1 Wuxi APP Neurological Biomarkers Basic Information
9.13.2 Wuxi APP Neurological Biomarkers Product Overview
9.13.3 Wuxi APP Neurological Biomarkers Product Market Performance
9.13.4 Wuxi APP Business Overview
9.13.5 Wuxi APP Recent Developments
9.14 Aepodia
9.14.1 Aepodia Neurological Biomarkers Basic Information
9.14.2 Aepodia Neurological Biomarkers Product Overview
9.14.3 Aepodia Neurological Biomarkers Product Market Performance
9.14.4 Aepodia Business Overview
9.14.5 Aepodia Recent Developments
9.15 Proteome Sciences
9.15.1 Proteome Sciences Neurological Biomarkers Basic Information
9.15.2 Proteome Sciences Neurological Biomarkers Product Overview
9.15.3 Proteome Sciences Neurological Biomarkers Product Market Performance
9.15.4 Proteome Sciences Business Overview
9.15.5 Proteome Sciences Recent Developments
9.16 Genewiz
9.16.1 Genewiz Neurological Biomarkers Basic Information
9.16.2 Genewiz Neurological Biomarkers Product Overview
9.16.3 Genewiz Neurological Biomarkers Product Market Performance
9.16.4 Genewiz Business Overview
9.16.5 Genewiz Recent Developments
10 NEUROLOGICAL BIOMARKERS MARKET FORECAST BY REGION
10.1 Global Neurological Biomarkers Market Size Forecast
10.2 Global Neurological Biomarkers Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neurological Biomarkers Market Size Forecast by Country
10.2.3 Asia Pacific Neurological Biomarkers Market Size Forecast by Region
10.2.4 South America Neurological Biomarkers Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neurological Biomarkers by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Neurological Biomarkers Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neurological Biomarkers by Type (2025-2030)
11.1.2 Global Neurological Biomarkers Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neurological Biomarkers by Type (2025-2030)
11.2 Global Neurological Biomarkers Market Forecast by Application (2025-2030)
11.2.1 Global Neurological Biomarkers Sales (Kilotons) Forecast by Application
11.2.2 Global Neurological Biomarkers Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neurological Biomarkers Market Size Comparison by Region (M USD)
Table 5. Global Neurological Biomarkers Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Neurological Biomarkers Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Neurological Biomarkers Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Neurological Biomarkers Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Biomarkers as of 2022)
Table 10. Global Market Neurological Biomarkers Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Neurological Biomarkers Sales Sites and Area Served
Table 12. Manufacturers Neurological Biomarkers Product Type
Table 13. Global Neurological Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neurological Biomarkers
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neurological Biomarkers Market Challenges
Table 22. Global Neurological Biomarkers Sales by Type (Kilotons)
Table 23. Global Neurological Biomarkers Market Size by Type (M USD)
Table 24. Global Neurological Biomarkers Sales (Kilotons) by Type (2019-2024)
Table 25. Global Neurological Biomarkers Sales Market Share by Type (2019-2024)
Table 26. Global Neurological Biomarkers Market Size (M USD) by Type (2019-2024)
Table 27. Global Neurological Biomarkers Market Size Share by Type (2019-2024)
Table 28. Global Neurological Biomarkers Price (USD/Ton) by Type (2019-2024)
Table 29. Global Neurological Biomarkers Sales (Kilotons) by Application
Table 30. Global Neurological Biomarkers Market Size by Application
Table 31. Global Neurological Biomarkers Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Neurological Biomarkers Sales Market Share by Application (2019-2024)
Table 33. Global Neurological Biomarkers Sales by Application (2019-2024) & (M USD)
Table 34. Global Neurological Biomarkers Market Share by Application (2019-2024)
Table 35. Global Neurological Biomarkers Sales Growth Rate by Application (2019-2024)
Table 36. Global Neurological Biomarkers Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Neurological Biomarkers Sales Market Share by Region (2019-2024)
Table 38. North America Neurological Biomarkers Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Neurological Biomarkers Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Neurological Biomarkers Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Neurological Biomarkers Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Neurological Biomarkers Sales by Region (2019-2024) & (Kilotons)
Table 43. Thermo Fisher Scientific Neurological Biomarkers Basic Information
Table 44. Thermo Fisher Scientific Neurological Biomarkers Product Overview
Table 45. Thermo Fisher Scientific Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Thermo Fisher Scientific Business Overview
Table 47. Thermo Fisher Scientific Neurological Biomarkers SWOT Analysis
Table 48. Thermo Fisher Scientific Recent Developments
Table 49. Merck Neurological Biomarkers Basic Information
Table 50. Merck Neurological Biomarkers Product Overview
Table 51. Merck Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Neurological Biomarkers SWOT Analysis
Table 54. Merck Recent Developments
Table 55. Quest Diagnostics Neurological Biomarkers Basic Information
Table 56. Quest Diagnostics Neurological Biomarkers Product Overview
Table 57. Quest Diagnostics Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Quest Diagnostics Neurological Biomarkers SWOT Analysis
Table 59. Quest Diagnostics Business Overview
Table 60. Quest Diagnostics Recent Developments
Table 61. Abbott Neurological Biomarkers Basic Information
Table 62. Abbott Neurological Biomarkers Product Overview
Table 63. Abbott Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Abbott Business Overview
Table 65. Abbott Recent Developments
Table 66. Roche Neurological Biomarkers Basic Information
Table 67. Roche Neurological Biomarkers Product Overview
Table 68. Roche Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Roche Business Overview
Table 70. Roche Recent Developments
Table 71. Illumina Neurological Biomarkers Basic Information
Table 72. Illumina Neurological Biomarkers Product Overview
Table 73. Illumina Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Illumina Business Overview
Table 75. Illumina Recent Developments
Table 76. Bio-Rad Laboratories Neurological Biomarkers Basic Information
Table 77. Bio-Rad Laboratories Neurological Biomarkers Product Overview
Table 78. Bio-Rad Laboratories Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Bio-Rad Laboratories Business Overview
Table 80. Bio-Rad Laboratories Recent Developments
Table 81. QIAGEN Neurological Biomarkers Basic Information
Table 82. QIAGEN Neurological Biomarkers Product Overview
Table 83. QIAGEN Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. QIAGEN Business Overview
Table 85. QIAGEN Recent Developments
Table 86. Myriad RBM Neurological Biomarkers Basic Information
Table 87. Myriad RBM Neurological Biomarkers Product Overview
Table 88. Myriad RBM Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Myriad RBM Business Overview
Table 90. Myriad RBM Recent Developments
Table 91. Cisbio Bioassays Neurological Biomarkers Basic Information
Table 92. Cisbio Bioassays Neurological Biomarkers Product Overview
Table 93. Cisbio Bioassays Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Cisbio Bioassays Business Overview
Table 95. Cisbio Bioassays Recent Developments
Table 96. Athena Diagnostics Neurological Biomarkers Basic Information
Table 97. Athena Diagnostics Neurological Biomarkers Product Overview
Table 98. Athena Diagnostics Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Athena Diagnostics Business Overview
Table 100. Athena Diagnostics Recent Developments
Table 101. BGI Neurological Biomarkers Basic Information
Table 102. BGI Neurological Biomarkers Product Overview
Table 103. BGI Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. BGI Business Overview
Table 105. BGI Recent Developments
Table 106. Wuxi APP Neurological Biomarkers Basic Information
Table 107. Wuxi APP Neurological Biomarkers Product Overview
Table 108. Wuxi APP Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Wuxi APP Business Overview
Table 110. Wuxi APP Recent Developments
Table 111. Aepodia Neurological Biomarkers Basic Information
Table 112. Aepodia Neurological Biomarkers Product Overview
Table 113. Aepodia Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Aepodia Business Overview
Table 115. Aepodia Recent Developments
Table 116. Proteome Sciences Neurological Biomarkers Basic Information
Table 117. Proteome Sciences Neurological Biomarkers Product Overview
Table 118. Proteome Sciences Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Proteome Sciences Business Overview
Table 120. Proteome Sciences Recent Developments
Table 121. Genewiz Neurological Biomarkers Basic Information
Table 122. Genewiz Neurological Biomarkers Product Overview
Table 123. Genewiz Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Genewiz Business Overview
Table 125. Genewiz Recent Developments
Table 126. Global Neurological Biomarkers Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Neurological Biomarkers Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Neurological Biomarkers Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Neurological Biomarkers Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Neurological Biomarkers Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Neurological Biomarkers Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Neurological Biomarkers Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Neurological Biomarkers Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Neurological Biomarkers Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Neurological Biomarkers Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Neurological Biomarkers Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Neurological Biomarkers Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Neurological Biomarkers Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Neurological Biomarkers Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Neurological Biomarkers Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Neurological Biomarkers Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Neurological Biomarkers Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neurological Biomarkers Market Size Comparison by Region (M USD)
Table 5. Global Neurological Biomarkers Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Neurological Biomarkers Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Neurological Biomarkers Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Neurological Biomarkers Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Biomarkers as of 2022)
Table 10. Global Market Neurological Biomarkers Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Neurological Biomarkers Sales Sites and Area Served
Table 12. Manufacturers Neurological Biomarkers Product Type
Table 13. Global Neurological Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neurological Biomarkers
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neurological Biomarkers Market Challenges
Table 22. Global Neurological Biomarkers Sales by Type (Kilotons)
Table 23. Global Neurological Biomarkers Market Size by Type (M USD)
Table 24. Global Neurological Biomarkers Sales (Kilotons) by Type (2019-2024)
Table 25. Global Neurological Biomarkers Sales Market Share by Type (2019-2024)
Table 26. Global Neurological Biomarkers Market Size (M USD) by Type (2019-2024)
Table 27. Global Neurological Biomarkers Market Size Share by Type (2019-2024)
Table 28. Global Neurological Biomarkers Price (USD/Ton) by Type (2019-2024)
Table 29. Global Neurological Biomarkers Sales (Kilotons) by Application
Table 30. Global Neurological Biomarkers Market Size by Application
Table 31. Global Neurological Biomarkers Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Neurological Biomarkers Sales Market Share by Application (2019-2024)
Table 33. Global Neurological Biomarkers Sales by Application (2019-2024) & (M USD)
Table 34. Global Neurological Biomarkers Market Share by Application (2019-2024)
Table 35. Global Neurological Biomarkers Sales Growth Rate by Application (2019-2024)
Table 36. Global Neurological Biomarkers Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Neurological Biomarkers Sales Market Share by Region (2019-2024)
Table 38. North America Neurological Biomarkers Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Neurological Biomarkers Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Neurological Biomarkers Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Neurological Biomarkers Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Neurological Biomarkers Sales by Region (2019-2024) & (Kilotons)
Table 43. Thermo Fisher Scientific Neurological Biomarkers Basic Information
Table 44. Thermo Fisher Scientific Neurological Biomarkers Product Overview
Table 45. Thermo Fisher Scientific Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Thermo Fisher Scientific Business Overview
Table 47. Thermo Fisher Scientific Neurological Biomarkers SWOT Analysis
Table 48. Thermo Fisher Scientific Recent Developments
Table 49. Merck Neurological Biomarkers Basic Information
Table 50. Merck Neurological Biomarkers Product Overview
Table 51. Merck Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Neurological Biomarkers SWOT Analysis
Table 54. Merck Recent Developments
Table 55. Quest Diagnostics Neurological Biomarkers Basic Information
Table 56. Quest Diagnostics Neurological Biomarkers Product Overview
Table 57. Quest Diagnostics Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Quest Diagnostics Neurological Biomarkers SWOT Analysis
Table 59. Quest Diagnostics Business Overview
Table 60. Quest Diagnostics Recent Developments
Table 61. Abbott Neurological Biomarkers Basic Information
Table 62. Abbott Neurological Biomarkers Product Overview
Table 63. Abbott Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Abbott Business Overview
Table 65. Abbott Recent Developments
Table 66. Roche Neurological Biomarkers Basic Information
Table 67. Roche Neurological Biomarkers Product Overview
Table 68. Roche Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Roche Business Overview
Table 70. Roche Recent Developments
Table 71. Illumina Neurological Biomarkers Basic Information
Table 72. Illumina Neurological Biomarkers Product Overview
Table 73. Illumina Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Illumina Business Overview
Table 75. Illumina Recent Developments
Table 76. Bio-Rad Laboratories Neurological Biomarkers Basic Information
Table 77. Bio-Rad Laboratories Neurological Biomarkers Product Overview
Table 78. Bio-Rad Laboratories Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Bio-Rad Laboratories Business Overview
Table 80. Bio-Rad Laboratories Recent Developments
Table 81. QIAGEN Neurological Biomarkers Basic Information
Table 82. QIAGEN Neurological Biomarkers Product Overview
Table 83. QIAGEN Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. QIAGEN Business Overview
Table 85. QIAGEN Recent Developments
Table 86. Myriad RBM Neurological Biomarkers Basic Information
Table 87. Myriad RBM Neurological Biomarkers Product Overview
Table 88. Myriad RBM Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Myriad RBM Business Overview
Table 90. Myriad RBM Recent Developments
Table 91. Cisbio Bioassays Neurological Biomarkers Basic Information
Table 92. Cisbio Bioassays Neurological Biomarkers Product Overview
Table 93. Cisbio Bioassays Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Cisbio Bioassays Business Overview
Table 95. Cisbio Bioassays Recent Developments
Table 96. Athena Diagnostics Neurological Biomarkers Basic Information
Table 97. Athena Diagnostics Neurological Biomarkers Product Overview
Table 98. Athena Diagnostics Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Athena Diagnostics Business Overview
Table 100. Athena Diagnostics Recent Developments
Table 101. BGI Neurological Biomarkers Basic Information
Table 102. BGI Neurological Biomarkers Product Overview
Table 103. BGI Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. BGI Business Overview
Table 105. BGI Recent Developments
Table 106. Wuxi APP Neurological Biomarkers Basic Information
Table 107. Wuxi APP Neurological Biomarkers Product Overview
Table 108. Wuxi APP Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Wuxi APP Business Overview
Table 110. Wuxi APP Recent Developments
Table 111. Aepodia Neurological Biomarkers Basic Information
Table 112. Aepodia Neurological Biomarkers Product Overview
Table 113. Aepodia Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Aepodia Business Overview
Table 115. Aepodia Recent Developments
Table 116. Proteome Sciences Neurological Biomarkers Basic Information
Table 117. Proteome Sciences Neurological Biomarkers Product Overview
Table 118. Proteome Sciences Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Proteome Sciences Business Overview
Table 120. Proteome Sciences Recent Developments
Table 121. Genewiz Neurological Biomarkers Basic Information
Table 122. Genewiz Neurological Biomarkers Product Overview
Table 123. Genewiz Neurological Biomarkers Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Genewiz Business Overview
Table 125. Genewiz Recent Developments
Table 126. Global Neurological Biomarkers Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Neurological Biomarkers Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Neurological Biomarkers Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Neurological Biomarkers Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Neurological Biomarkers Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Neurological Biomarkers Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Neurological Biomarkers Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Neurological Biomarkers Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Neurological Biomarkers Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Neurological Biomarkers Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Neurological Biomarkers Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Neurological Biomarkers Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Neurological Biomarkers Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Neurological Biomarkers Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Neurological Biomarkers Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Neurological Biomarkers Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Neurological Biomarkers Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Neurological Biomarkers
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurological Biomarkers Market Size (M USD), 2019-2030
Figure 5. Global Neurological Biomarkers Market Size (M USD) (2019-2030)
Figure 6. Global Neurological Biomarkers Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neurological Biomarkers Market Size by Country (M USD)
Figure 11. Neurological Biomarkers Sales Share by Manufacturers in 2023
Figure 12. Global Neurological Biomarkers Revenue Share by Manufacturers in 2023
Figure 13. Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neurological Biomarkers Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neurological Biomarkers Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neurological Biomarkers Market Share by Type
Figure 18. Sales Market Share of Neurological Biomarkers by Type (2019-2024)
Figure 19. Sales Market Share of Neurological Biomarkers by Type in 2023
Figure 20. Market Size Share of Neurological Biomarkers by Type (2019-2024)
Figure 21. Market Size Market Share of Neurological Biomarkers by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neurological Biomarkers Market Share by Application
Figure 24. Global Neurological Biomarkers Sales Market Share by Application (2019-2024)
Figure 25. Global Neurological Biomarkers Sales Market Share by Application in 2023
Figure 26. Global Neurological Biomarkers Market Share by Application (2019-2024)
Figure 27. Global Neurological Biomarkers Market Share by Application in 2023
Figure 28. Global Neurological Biomarkers Sales Growth Rate by Application (2019-2024)
Figure 29. Global Neurological Biomarkers Sales Market Share by Region (2019-2024)
Figure 30. North America Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Neurological Biomarkers Sales Market Share by Country in 2023
Figure 32. U.S. Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Neurological Biomarkers Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Neurological Biomarkers Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Neurological Biomarkers Sales Market Share by Country in 2023
Figure 37. Germany Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Neurological Biomarkers Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Neurological Biomarkers Sales Market Share by Region in 2023
Figure 44. China Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Neurological Biomarkers Sales and Growth Rate (Kilotons)
Figure 50. South America Neurological Biomarkers Sales Market Share by Country in 2023
Figure 51. Brazil Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Neurological Biomarkers Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Neurological Biomarkers Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Neurological Biomarkers Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Neurological Biomarkers Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Neurological Biomarkers Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Neurological Biomarkers Market Share Forecast by Type (2025-2030)
Figure 65. Global Neurological Biomarkers Sales Forecast by Application (2025-2030)
Figure 66. Global Neurological Biomarkers Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Neurological Biomarkers
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurological Biomarkers Market Size (M USD), 2019-2030
Figure 5. Global Neurological Biomarkers Market Size (M USD) (2019-2030)
Figure 6. Global Neurological Biomarkers Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neurological Biomarkers Market Size by Country (M USD)
Figure 11. Neurological Biomarkers Sales Share by Manufacturers in 2023
Figure 12. Global Neurological Biomarkers Revenue Share by Manufacturers in 2023
Figure 13. Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neurological Biomarkers Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neurological Biomarkers Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neurological Biomarkers Market Share by Type
Figure 18. Sales Market Share of Neurological Biomarkers by Type (2019-2024)
Figure 19. Sales Market Share of Neurological Biomarkers by Type in 2023
Figure 20. Market Size Share of Neurological Biomarkers by Type (2019-2024)
Figure 21. Market Size Market Share of Neurological Biomarkers by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neurological Biomarkers Market Share by Application
Figure 24. Global Neurological Biomarkers Sales Market Share by Application (2019-2024)
Figure 25. Global Neurological Biomarkers Sales Market Share by Application in 2023
Figure 26. Global Neurological Biomarkers Market Share by Application (2019-2024)
Figure 27. Global Neurological Biomarkers Market Share by Application in 2023
Figure 28. Global Neurological Biomarkers Sales Growth Rate by Application (2019-2024)
Figure 29. Global Neurological Biomarkers Sales Market Share by Region (2019-2024)
Figure 30. North America Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Neurological Biomarkers Sales Market Share by Country in 2023
Figure 32. U.S. Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Neurological Biomarkers Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Neurological Biomarkers Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Neurological Biomarkers Sales Market Share by Country in 2023
Figure 37. Germany Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Neurological Biomarkers Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Neurological Biomarkers Sales Market Share by Region in 2023
Figure 44. China Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Neurological Biomarkers Sales and Growth Rate (Kilotons)
Figure 50. South America Neurological Biomarkers Sales Market Share by Country in 2023
Figure 51. Brazil Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Neurological Biomarkers Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Neurological Biomarkers Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Neurological Biomarkers Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Neurological Biomarkers Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Neurological Biomarkers Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Neurological Biomarkers Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Neurological Biomarkers Market Share Forecast by Type (2025-2030)
Figure 65. Global Neurological Biomarkers Sales Forecast by Application (2025-2030)
Figure 66. Global Neurological Biomarkers Market Share Forecast by Application (2025-2030)
